"Israeli Scientists Develop Breakthrough Cancer Immunotherapy"

Israeli scientists at the Weizmann Institute of Science have developed a novel immunotherapy approach that combines T cells and dendritic cells to trigger a strong immune response against cancer. The study, published in Cell, showed promising results in reducing the growth rate of aggressive cancers in mice, and even proved effective against cancers resistant to immunotherapy. The researchers also found that the new treatment could prevent the development of secondary tumors, indicating a systemic immune response against cancer. This breakthrough offers hope for more targeted immune suppression in various diseases, and the scientists are now focused on developing a drug suitable for human treatment.